Back to News
Market Impact: 0.55

Martin Marietta Materials stock price target raised to $723 by UBS

TSLAUBSMLM
Analyst InsightsAnalyst EstimatesCorporate EarningsCompany FundamentalsCorporate Guidance & OutlookM&A & RestructuringCapital Returns (Dividends / Buybacks)Infrastructure & Defense

UBS raised its price target on Martin Marietta Materials (MLM) to $723 from $705, maintaining a Buy rating, following strong third-quarter results where aggregates pricing and volumes exceeded expectations, driving an EBITDA beat and EPS of $6.85, despite revenue of $1.85 billion falling short of projections. The firm anticipates MLM is well-positioned for 2026 due to stabilizing volumes and resilient pricing amid challenging U.S. construction markets, though InvestingPro data suggests the stock may be trading above its fair value.

Analysis

UBS has raised its price target for Martin Marietta Materials (MLM) to $723 from $705, maintaining a Buy rating, following the company's Q3 2025 results. While MLM reported an EPS of $6.85, surpassing expectations, and an EBITDA beat driven by strong aggregates pricing and volumes, its revenue of $1.85 billion fell short of the $2.06 billion projection by 10.19%. This indicates a mixed operational performance despite underlying strength in key segments. The company demonstrated robust operational execution, with a solid gross profit margin of 30.55% and accelerating gross profit per ton year-over-year in Q3, with further acceleration anticipated in Q4 due to improved cost performance. Martin Marietta's strategic plan to swap cement and concrete assets for aggregates, alongside its "GOOD" financial health score of 2.91 from InvestingPro, underscores a focused approach to its core business. UBS projects MLM is well-positioned for 2026, anticipating a reacceleration in U.S. construction activity in the second half, supported by stabilizing volumes and resilient pricing, despite current challenging market conditions. However, InvestingPro data suggests the stock may be trading above its fair value, presenting a valuation consideration even with the 19% potential upside to UBS's new target. The company's 32-year dividend payment streak and 9 consecutive years of increases highlight its financial stability.

AllMind AI Terminal

AI-powered research, real-time alerts, and portfolio analytics for institutional investors.

Request a Demo